Hepatic Safety of Ketamine and Esketamine for Treatment-Resistant Depression

Journal of Clinical Psychopharmacology · Published 2026-07-28 · DOI 10.1097/jcp.0000000000002228

Free full text

Authors (5)

Balwinder Singh, Jonathan G. Leung, Vanessa K. Pazdernik, Simon Kung, Jennifer L. Vande Voort

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Singh, B., Leung, J., Pazdernik, V., et al. (2026). Hepatic Safety of Ketamine and Esketamine for Treatment-Resistant Depression. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/jcp.0000000000002228

Related articles

• Early suicidal ideation change and suicidality-associated emergency department utilization after ketamine or esketamine treatment in treatment-resistant depression. · 2025 · Cites or is cited by this article
• Utility and limitations of the FDA adverse events reporting system public dashboard for safety analyses: a case study with vesicular monoamine transporter 2 inhibitors · Expert Opinion on Drug Safety · 2025 · Cites or is cited by this article
• Progress on Pharmacogenetic Tests for Antidepressant Drug Selection Requires Properly Designed Studies · Journal of Clinical Psychopharmacology · 2026 · Same journal
• Journal of Clinical Psychopharmacology Updates · Journal of Clinical Psychopharmacology · 2026 · Same journal
• Vortioxetine Related Hypertriglyceridemia in a Young Male · Journal of Clinical Psychopharmacology · 2026 · Same journal
• Sugarless Candy in Treatment-Resistant Clozapine-Induced Sialorrhea · Journal of Clinical Psychopharmacology · 2026 · Same journal
• Safety of Adjunct Low-Dose Methylphenidate Extended-Release for Cognitive Deficits in Stable Schizophrenia · Journal of Clinical Psychopharmacology · 2026 · Same journal
• Menorrhagia Associated With Extended-Release Methylphenidate in an Adult Woman · Journal of Clinical Psychopharmacology · 2026 · Same journal
• Hypnopompic Hallucinations · Journal of Clinical Psychopharmacology · 2026 · Same journal
• Reading the Signal: What Psychedelic Trials in Depression Still Can’t Tell Us · Journal of Clinical Psychopharmacology · 2026 · Same journal